Digital Biomarkers

Overview

An algorithm has marked cell nuclei in Ki67-stained breast tissue, permitting the quantification of proliferation.
© Fraunhofer MEVIS
  • Digital biomarkers are quantifiable parameters of patients that enable computer-aided targeted diagnostics and personalized medicine.

  • We develop AI tools to analyze pathology images and develop novel biomarkers in an experienced team with diverse scientific, clinical, and technical expertise.

  • We collaborate with a wide network of clinical, industry and academic partners in joint research and contract R&D projects in biomarker research and digital pathology.

  • Our software solutions aid in disease diagnostics, reducing the workload of pathologists, enabling more effective treatment, and ultimately reducing healthcare costs.

  • We support the entire development cycle comprising exploratory scientific research, development of usable prototypical software tools, and translation into marketable IVDs.

Focus Areas

The image shows a joint visualization of differently stained images from histopathology (HE & IHC).
https://doi.org/p7x8 (CC BY-SA)
  • Digital Biomarker R&D. We support clinical and pharmaceutical research studies in data-driven identification of novel biomarkers based on images and other clinical data.

  • Image & Data Analysis. We develop algorithms for robust qualitative and quantitative analysis of microscopic images and clinically relevant data.

  • Software IVD Development. We develop practical software solutions and help translate them into marketable in-vitro diagnostics.

  • Image Registration. We enable you to combine information from multiple serial sections with award-winning accuracy and performance.
    →  HistokatFusion

Research Topics

A bone marrow smear is automatically analyzed by first detecting the monolayer area, followed by cell detection and eventually cell classification.
© Fraunhofer MEVIS
  • Meaningful Digital Biomarkers. We develop algorithms to quantify morphology and molecular information in its spatial context to explore clinically meaningful biomarkers.
    → Meaningful Digital Biomarkers
  • Hemato-Oncology. We develop AI-driven algorithms for the analysis of blood and bone marrow cells to diagnose hemato-onlological diseases.
    → Hemato-oncology
  • Image Registration. We integrate multi-stain information from multiple slides using image registration for histopathology image analysis.
    → HistokatFusion
  • Federated Learning. We develop privacy-preserving federated AI models, enabling collaborative learning across multiple labs for joint research projects.
  • Data Acquisition and Curation. We have expertise in selecting representative and unbiased collections for AI development and data analysis in pathology.
  • Develop Software IVDs. We have many years of experience in the development of software solutions for clinical practice.
    → Develop Software IVDs

Highlights

Fluorescence in-situ hybridization of ERBB2 amplification: automated signal counting for breast cancer assessment
https://doi.org/ghcp9g (CC BY-NC-ND)
  • Data-Driven Discovery of Immune Contexture Biomarkers. Schwen et al. 2018. article
  • Artificial Intelligence in Pathology: From Prototype to Product. Homeyer et al. 2022. article
  • Recommendations on compiling test datasets for evaluating artificial intelligence solutions in pathology. Homeyer et al. 2022. article
  • The NCI Imaging Data Commons as a platform for reproducible research in computational pathology. Schacherer et al. 2023. article
  • Overcoming data scarcity in biomedical imaging with a foundational multi-task model. Schaefer et al. 2024. article

 

Contact Press / Media

Dr. rer. nat. Johannes Lotz

Principal Scientist Computational Pathology, Image Registration

Fraunhofer Institute for Digital Medicine MEVIS
Maria-Goeppert-Str. 3
23562 Lübeck

Phone +49 451 3101-6118

Fax +49 451 3101-6104

Contact Press / Media

Dr.-Ing. Henning Höfener

Principal Scientist Computational Pathology

Fraunhofer Institute for Digital Medicine MEVIS
Max-von-Laue-Str. 2
28359 Bremen

Phone +49 421 17879 2147